Home LiteratureArticle Details
PMID: 10482568 Published · ppublish English Journal Article

Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited.

Journal of virology ·Vol. 73 ·No. 10 ·1999-10-00 ·Pages 8179-84

Kern F, Surel IP, Faulhaber N, Frömmel C, Schneider-Mergener J, Schönemann C, Reinke P, Volk HD

Abstract

Cell-mediated immunity plays an essential role in the control of infection with the human cytomegalovirus (HCMV). However, only a few CD8(+)-T-cell epitopes are known, with the majority being contained in the pp65 phosphoprotein, which is believed to dominate the CD8(+)-T-cell response to HCMV. Here, we have readdressed the issue of CD8(+) T cells specific for the 72-kDa major immediate-early protein (IE-1), which is nonstructural but is found very early and throughout the replicative cycle. Using a novel flow-cytometric assay, we were able to identify CD8(+)-T-cell epitopes (by IE-1 peptide-specific induction of cytokine synthesis) and simultaneously measure the frequency of cells directed against them. For this purpose, 81 pentadecamer peptides covering the complete 491-amino-acid sequence of IE-1 were tested on peripheral blood mononuclear cells of anti-HCMV immunoglobulin G-seropositive donors. At least 10 new epitopes were identified, and the fine specificity and presenting HLA molecule of the first of them was determined. The frequencies of CD8(+) T cells directed against IE-1 were similar to those directed against pp65 in donors tested with known pp65-derived peptides. Importantly, additional testing of a corresponding set of peptides covering the complete sequence of pp65 on 10 of these donors identified individuals whose CD8(+) T cells recognized IE-1 but not pp65 and vice versa, clearly illustrating that either protein may be a major target. In summary, our results suggest that IE-1 is far more important as a CD8(+)-T-cell target than current opinion suggests.

MeSH Terms
Antigen Presentation Antigens, Viral/immunology CD8-Positive T-Lymphocytes/immunology,virology Cytomegalovirus/immunology Cytomegalovirus Infections/immunology Epitopes/immunology Humans Immediate-Early Proteins/immunology Immunity, Cellular Interferon-gamma/immunology Trans-Activators/immunology
Chemicals
Antigens, Viral Epitopes IE-1 protein, murine cytomegalovirus Immediate-Early Proteins Trans-Activators Interferon-gamma
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Kern F
Institut für Medizinische Immunologie, Medizinische Fakultät der Humboldt-Universität zu Berlin (Charité), 10098 Berlin, Germany. florian.kern@charite.de
Surel I P
Faulhaber N
Frömmel C
Schneider-Mergener J
Schönemann C
Reinke P
Volk H D
References (23)
23 references, click to expand
  1. Selective reconstitution of CD8+ cytotoxic T lymphocyte responses in immunodeficient bone marrow transplant recipients by the adoptive transfer of T cell clones.
    Bone Marrow Transplant. 1994;14 Suppl 4:S78-84 PMID: 7728132
  2. MHC ligands and peptide motifs: first listing.
    Immunogenetics. 1995;41(4):178-228 PMID: 7890324
  3. PCR activity of CMV in healthy CMV-seropositive individuals: does latency need redefinition?
    Res Virol. 1996 Jul-Aug;147(4):233-8 PMID: 8837231
  4. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product.
    Nature. 1996 Oct 24;383(6602):720-2 PMID: 8878482
  5. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
    J Virol. 1996 Nov;70(11):7569-79 PMID: 8892876
  6. Cytomegalovirus induced up-regulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment.
    Transplantation. 1996 Oct 27;62(8):1102-8 PMID: 8900310
  7. Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection.
    Blood. 1997 Sep 1;90(5):1751-67 PMID: 9292508
  8. T-cell epitope mapping by flow cytometry.
    Nat Med. 1998 Aug;4(8):975-8 PMID: 9701254
  9. Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins.
    Transplantation. 1999 Jan 15;67(1):137-44 PMID: 9921810
  10. SYFPEITHI: database for MHC ligands and peptide motifs.
    Immunogenetics. 1999 Nov;50(3-4):213-9 PMID: 10602881
  11. Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients.
    N Engl J Med. 1982 Jul 1;307(1):7-13 PMID: 6281647
  12. HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infections.
    Rev Infect Dis. 1984 Mar-Apr;6(2):156-63 PMID: 6328614
  13. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses.
    J Exp Med. 1988 Sep 1;168(3):919-31 PMID: 2844952
  14. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.
    Nature. 1991 May 23;351(6324):290-6 PMID: 1709722
  15. Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early 1 protein.
    J Virol. 1991 Sep;65(9):4812-20 PMID: 1714519
  16. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease.
    Blood. 1991 Sep 1;78(5):1373-80 PMID: 1652311
  17. Cytotoxic T cells specific for cytomegalovirus: a potential therapy for immunocompromised patients.
    Rev Infect Dis. 1991 Nov-Dec;13 Suppl 11:S966-73 PMID: 1664137
  18. Development of a treatment regimen for human cytomegalovirus (CMV) infection in bone marrow transplantation recipients by adoptive transfer of donor-derived CMV-specific T cell clones expanded in vitro.
    Ann N Y Acad Sci. 1991 Dec 30;636:184-95 PMID: 1665321
  19. Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes.
    J Immunol. 1993 Oct 15;151(8):3971-80 PMID: 7691936
  20. Cytomegalovirus reactivation and tumour necrosis factor.
    Lancet. 1994 Jan 29;343(8892):268-9 PMID: 7905100
  21. Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes.
    J Med Virol. 1994 May;43(1):103-10 PMID: 8083644
  22. Analysis of a naturally occurring HLA class I-restricted viral epitope.
    Immunology. 1994 Jul;82(3):337-42 PMID: 7525458
  23. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.
    N Engl J Med. 1995 Oct 19;333(16):1038-44 PMID: 7675046
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1999-10-00
Pages
8179-84
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC112835
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com